These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21129210)
1. Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy. Zubac DP; Wentzel-Larsen T; Seidal T; Bostad L BMC Urol; 2010 Dec; 10():20. PubMed ID: 21129210 [TBL] [Abstract][Full Text] [Related]
2. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival. Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660 [TBL] [Abstract][Full Text] [Related]
3. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177 [TBL] [Abstract][Full Text] [Related]
4. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Parker AS; Eckel-Passow JE; Serie D; Hilton T; Parasramka M; Joseph RW; Wu KJ; Cheville JC; Leibovich BC Eur Urol; 2014 Nov; 66(5):929-35. PubMed ID: 24388441 [TBL] [Abstract][Full Text] [Related]
5. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma. Laba P; Wang J; Zhang J BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799 [TBL] [Abstract][Full Text] [Related]
6. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma. Choi JW; Lee JH; Park HS; Kim YS J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth inhibitor 174 is a negative regulator of aggressiveness and microvascular density in human clear cell renal cell carcinoma. Wu L; Li X; Ye L; Shayiremu D; Deng X; Zhang X; Jiang W; Yang Y; Gong K; Zhang N Anticancer Res; 2014 Feb; 34(2):715-22. PubMed ID: 24511004 [TBL] [Abstract][Full Text] [Related]
8. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma. Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis. Fuessel S; Erdmann K; Taubert H; Lohse-Fischer A; Zastrow S; Meinhardt M; Bluemke K; Hofbauer L; Fornara P; Wullich B; Baretton G; Magdolen V; Wirth MP; Kotzsch M BMC Cancer; 2014 Dec; 14():974. PubMed ID: 25519168 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma. Zhang JP; Yuan HX; Kong WT; Liu Y; Lin ZM; Wangs WP; Guo JM Tumour Biol; 2014 Dec; 35(12):12131-7. PubMed ID: 25142236 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
13. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. Joo HJ; Oh DK; Kim YS; Lee KB; Kim SJ BJU Int; 2004 Feb; 93(3):291-6. PubMed ID: 14764125 [TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
16. Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations. Qin C; Sun LJ; Cui L; Cao Q; Zhu J; Li P; Zhang GM; Mao X; Shao PF; Wang ML; Zhang ZD; Gu M; Zhang W; Yin CJ Asian J Androl; 2013 Jul; 15(4):550-7. PubMed ID: 23564046 [TBL] [Abstract][Full Text] [Related]
18. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448 [TBL] [Abstract][Full Text] [Related]
19. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]